Barbara L. Waszczak, Ph.D.
Affiliations: | Pharmaceutical Science | Northeastern University, Boston, MA, United States |
Area:
Parkinson's disease, intranasal delivery, dopamine signalingGoogle:
"Barbara Waszczak"Mean distance: 35622
Cross-listing: Neuropathology Tree
Children
Sign in to add trainee| Mattia M. Migliore | grad student | 2008 | Northeastern University |
| Brendan T. Harmon | grad student | 2007-2013 | Northeastern University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Aly AE, Sun T, Zhang Y, et al. (2023) Focused ultrasound enhances transgene expression of intranasal hGDNF DNA nanoparticles in the sonicated brain regions. Journal of Controlled Release : Official Journal of the Controlled Release Society |
| Aly AE, Harmon B, Padegimas L, et al. (2018) Intranasal delivery of hGDNF plasmid DNA nanoparticles results in long-term and widespread transfection of perivascular cells in rat brain. Nanomedicine : Nanotechnology, Biology, and Medicine |
| Cai X, Qiao J, Knox T, et al. (2018) In search of early neuroradiological biomarkers for Parkinson's Disease: Alterations in resting state functional connectivity and gray matter microarchitecture in PINK1 -/- rats. Brain Research |
| Aly AE, Harmon BT, Padegimas L, et al. (2018) Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson's Disease. Molecular Neurobiology |
| Aly AE, Waszczak BL. (2015) Intranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrier. Expert Opinion On Drug Delivery. 1-19 |
| Bender TS, Migliore MM, Campbell RB, et al. (2015) Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in rats. Neuroscience. 303: 569-576 |
| Migliore MM, Ortiz R, Dye S, et al. (2014) Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease. Neuroscience. 274: 11-23 |
| Harmon BT, Aly AE, Padegimas L, et al. (2014) Intranasal administration of plasmid DNA nanoparticles yields successful transfection and expression of a reporter protein in rat brain. Gene Therapy. 21: 514-21 |
| Migliore MM, Vyas TK, Campbell RB, et al. (2010) Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations. Journal of Pharmaceutical Sciences. 99: 1745-61 |
| Kilpatrick GJ, McIntyre MS, Cox RF, et al. (2007) CNS 7056: a novel ultra-short-acting Benzodiazepine. Anesthesiology. 107: 60-6 |